This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports


With shares up more than 19% off recent lows, we will trim our position.

Alcoa Shows China May Be Worse Than We Thought: Jim Cramer

The biggest takeaway from Alcoa's earnings? Cutting back on production in China, indicating big problems still need fixing in that country's economy.

Consumers Are Finally Spending Their Gas Savings: Jim Cramer

More money for consumers means more money for the companies that serve them.

Energy Transfer Has Pipeline to Turnaround

Upgrade could mark pivot point for MLP unfairly hampered by energy sector events.

This Time, China Means Business (Doesn't It?)

Much of the strength of the U.S. market in the last few days comes from a belief that Chinese government actions are, at last, working to reboot its economy.

Selling Some Starwood Into Strength

With shares outperforming the broader market today, we'll trim our position.

Biogen's MS Drug Trials Beat Competitors’ Results

We believe the biotech's multiple sclerosis treatment, MT-1303, could boost its market-leading position.

What Upgrade Says About Morgan Stanley

Shares have rebounded; wealth management remains a strength.

Jim Cramer -- Microsoft, General Mills, WhiteWave Are Buying Opportunities

Jim Cramer answers viewers questions from social media on the floor of the New York Stock Exchange.

Downgrading Dow Chemical

We would trim our position if not restricted, as major catalysts appear to have largely played out.

Page 1 of 1632
< Previous
Top Rated Stocks Top Rated Funds Top Rated ETFs